Para fornecer o conteúdo mais relevante aos leitores do HealthCare Business News, pedimos que você compartilhe um pouco de informação sobre quem você é (leva dois segundos e pronto).
Registo
Mevion S250 proton therapy accelerator arrives in Georgetown
por Gus Iversen, Editor in Chief | February 19, 2016
In the following promotional video produced by Mevion, the company spoke to representatives from the organizations utilizing their equipment to help potential customers understand the company's value proposition:
MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The Ackerman Cancer Center is currently in the process of adding a second Mevion system to its facility. Its MEVION S250i, with HYPERSCAN pencil beam capabilities, is expected to be fully installed next year.
Last summer, when HCB News asked Jachinowski what the global MEVION S250 install base might look like five years from now, he estimated somewhere in the ballpark of 40 facilities.
About a month later, the proton therapy OEM announced an investment agreement with HOPU Investments, YuanMing Capital, and participated in by other Chinese investors and U.S. investors, where up to $200 million would be invested in Mevion to accelerate its worldwide expansion. Back to HCB News
